Facebook
Twitter
LinkedIn
ForwardWisconsin Society of Otolaryngology Meeting 2024
Dates and Location
October 19-20, 2024
Kalahari Resort
1305 Kalahari Drive
Wisconsin Dells, Wisconsin
Meeting Format
This activity will be held in-person at the Kalahari Resort, Wisconsin Dells, Wisconsin.
Jointly Provided by
- Wisconsin Society of Otolaryngology
- University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP)
Intended Audience
This activity is intended for otolaryngologists and advanced practice providers who treat otolaryngologic conditions.
Elements of Competence
This continuing education activity has been designed to change learner competence and focuses on the American Board of Medical Specialties areas of medical knowledge, systems-based practice, and the interprofessional competency of roles/responsibilities.
Learning Objectives
As a result of participation in this educational activity, members of the healthcare team will be able to:
- Determine where to access the latest research, guidelines, and advancements in laryngology
- Identify and advocate for essential diagnostic tools and therapeutic options to ensure all patients have access to optimal treatment
- Implement strategies to enhance communication among healthcare providers and patients to minimize misunderstandings and improve care coordination
Program Dates: October 19-20, 2024
| Saturday, October 19, 2024 | |
| AM | |
| 7:00 | Registration and Breakfast |
| 7:30 | Welcome, Mike Harris, MD |
| 7:35 | Translating Science to Treatment in Idiopathic Subglottic Stenosis, Where Are We Now, Alexander Gelbard, MD |
| 8:35 | National Trends in Treatment of Acute Unilateral Vocal Fold Paralysis, Nicholas Colwell, MD |
| 8:42 | Do Patients Treated with Teprotumumab Meet American Speech-Language-Hearing Association (ASHA) Criteria for Ototoxicity, Oliwia Mlodawska, MS |
| 8:49 | Investigating the Mechanisms and Therapeutic Potential of CXCL12 Locked Dimer in Combination with Radiotherapy for Head and Neck Cancer, Oscar Villarreal Espinosa, MS |
| 8:56 | Thyroid Nodule Workup - The Role of Race and Insurance, Hayley Mann, MD |
| 9:03 | Assessment of Modes of Anesthesia for Cochlear Implant Surgery, Phuong Bao, MS |
| 9:10 | Correlation Between Tinnitus and Life Stress, Bea Mumm, MS |
| 9:17 | A Prospective Double-Blinded Comparison of Reflectance Confocal Microscopy with Conventional Histopathology for In-Vivo Assessment in Oral Cancer, Paula Demetrio de Souza France, MD |
| 9:23 | Characterizing the Human Membranous Labyrinth Position within the Lateral Semicircular Canal: A Histologic Analysis and Proposal for Pathology-Guided Classification, Koffi Lord Lorentz Leonard Lakpa, MD |
| 9:30 | Break |
| 9:45 | Trends in Perioperative Management of Pediatric Esophageal Button Battery Ingestions, Monica Lewis, MS |
| 9:52 | PTC with Aggressive Rare Distant Metastases: A Case Report, Monet McCalla, MD |
| 10:00 | Tinnitus in Children: When Is It More Than Just Bothersome Ringing, Ian Joseph Rodriguez, MS |
| 10:07 | Investigating the Role of Reflux and Pepsin in Non-Allergic Rhinitis, Simon Blaine-Sauer, MS |
| 10:17 | Creation of a Comprehensive Cochlear Implant Program at the Clement J. Zablocki VA Medical Center, Edward Harwick, MS |
| 10:23 | Pediatric Tonsillectomy Following Videofluoroscopic Swallow Study Evaluation, Riley McCarty, MS |
| 10:30 | Seizure as the Presenting Symptom of Acute Mastoiditis with Epidural Abscess and Cerebritis, Caleb Ganansky, MS |
| 10:37 | Auditory Training for Cochlear Implant Recipients, Sarah Melin, MS |
| 10:45 | Newborn Hearing Screening Metrics According to Level of Care: A Statewide Analysis Comparing NICU and Well-Baby Performance, Sabrina Huang, MS; Gisselle Garcia |
| 11:00 | In-office Procedures in Otolaryngology, Tyler Willman, MD |
| 11:15 | Reflux Testing Update for the Otolaryngologist, Jonathan Bock, MD |
| 11:30 | Congenital CMV Hearing Loss Overview and Advocacy, Adam Coughlin, MD |
| 11:40 | Laryngology Panel - Case Discussion, Joel Blumin, MD, Moderator; Panel Members: Jonathan Bock, MD; Ruth Davis, MD; Courtney Tipton, MD |
| 12:00 | Adjourn |
| Sunday, October 20, 2024 | |
| AM | |
| 7:30 | Breakfast |
| 8:30 | How to Alter the Course of Airway Injury After Endotracheal Intubation, Alexander Gelbard, MD |
| 9:30 | Surgical Pearls for Osia Bone Conduction, Michael Oldenburg, MD |
| 9:45 | Hearing Preservation During Cochlear Implant Surgery, Mike Harris, MD |
| 10:00 | Break |
| 10:15 | Initial Management of Tracheal Agenesis, Nathan Schreiber, MD |
| 10:30 | Acute Laryngeal Injury After Intubation, Ruth Davis, MD |
| 10:45 | Role of Superior Laryngeal Nerve Block in Chronic Cough Management, Courtney Tipton, MD |
| 11:00 | Presby-vestibulopathy: Guidelines and Recommendations, Katie Damon, PA-C |
| 11:15 | OSA/CPAP, Alex Shum, MD |
| 11:30 | Expanding Indications for Cochlear Implantation, Jason Brant, MD |
| 11:45 | "Tobacco" Cessation Update, Brian Sieck, MD |
| 12:00 | Adjourn |
Planning Committee
Adam Coughlin, MD
Mike Harris, MD
Delight Hensler
Brian Sieck, MD
Aaron Wieland, MD
Presenters
Phuong Bao, MS
Simon Blaine-Sauer, MS
Joel Blumin, MD
Jonathan Bock, MD
Jason Brant, MD
Nicholas Colwell, MD
Adam Coughlin, MD
Katie Damon, PA-C
Ruth Davis, MD
Paula Demetrio de Souza Franca, MD
Caleb Ganansky, MS
Gisselle Garcia
Alexander Gelbard, MD
Mike Harris, MD
Edward Harwick, MS
Sabrina Huang, MS
Monica Lewis, MS
Koffi Lord Lorentz Leonard Lakpa, MS
Hayley Mann, MD
Monet McCalla, MD
Riley McCarty, MS
Sarah Melin, MS
Oliwia Mlodawska, MS
Bea Mumm, MS
Michael Oldenburg, MD
Ian Joseph Rodriguez, MS
Nathan Schreiber, MD
Axel Shum, MD
Brian Sieck, MD
Courtney Tipton, MD
Oscar Villarreal Espinosa, MS
Tyler Willman, MD
Policy on Faculty and Sponsor Disclosure
It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate, and disclose all relevant financial relationships with ineligible companies* held by the speakers/presenters, authors, planners, and other persons who may influence the content of this accredited continuing education (CE). In addition, speakers, presenters, and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation(s). For this accredited continuing education activity all relevant financial relationships have been mitigated and detailed disclosures are listed below.
*Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on, patients. The ACCME does not consider providers of clinical services directly to patients to be commercial interests.
NAME |
ROLE(S) |
FINANCIAL RELATIONSHIPS DISCLOSURE | DISCUSSION OF UNLABELED/ UNAPPROVED USES OF DRUGS/DEVICES IN PRESENTATION |
Phuong Bao, MS | Speaker | No relevant relationships with ineligible companies to disclose | No |
Simon Blaine-Sauer, MS | Speaker | No relevant relationships with ineligible companies to disclose | Yes |
Joel Blumin, MD | Moderator | No relevant relationships with ineligible companies to disclose | No |
Jonathan Bock, MD | Speaker | No relevant relationships with ineligible companies to disclose | No |
Jason Brant, MD | Speaker | Amgen, Incyte (Both Contractor) | No |
Nicholas Colwell, MD | Speaker | No relevant relationships with ineligible companies to disclose | No |
| Adam Coughlin, MD | Committee Member, Speaker | No relevant relationships with ineligible companies to disclose | Yes |
| Katie Damon, PA-C | Speaker | No relevant relationships with ineligible companies to disclose | No |
| Ruth Davis, MD | Speaker | No relevant relationships with ineligible companies to disclose | Yes |
| Paula Demetrio de Souza Franca, MD | Speaker | No relevant relationships with ineligible companies to disclose | Yes |
| Caleb Ganansky, MS | Speaker | No relevant relationships with ineligible companies to disclose | No |
| Gisselle Garcia | Speaker | No relevant relationships with ineligible companies to disclose | No |
| Alexander Gelbard, MD | Speaker | No relevant relationships with ineligible companies to disclose | No |
Mike Harris, MD | Committee Member, Speaker | No relevant relationships with ineligible companies to disclose | No |
Edward Harwick, MS | Speaker | No relevant relationships with ineligible companies to disclose | No |
Delight Hensler | Committee Member | No relevant relationships with ineligible companies to disclose | N/A |
| Sabrina Huang, MS | Speaker | No relevant relationships with ineligible companies to disclose | No |
Monica Lewis, MS | Speaker | No relevant relationships with ineligible companies to disclose | No |
| Koffi Lord Lorentz Leonard Lakpa, MS | Speaker | No relevant relationships with ineligible companies to disclose | No |
Hayley Mann, MD | Speaker | No relevant relationships with ineligible companies to disclose | No |
Monica McCalla, MD | Speaker | No relevant relationships with ineligible companies to disclose | No |
Riley McCarty, MS | Speaker | No relevant relationships with ineligible companies to disclose | No |
Cathy Means | Planner | No relevant relationships with ineligible companies to disclose | N/A |
Sarah Melin, MS | Speaker | No relevant relationships with ineligible companies to disclose | No |
| Oliwia Mlodawaka, MS | Speaker | No relevant relationships with ineligible companies to disclose | No |
| Bea Mumm, MS | Speaker | No relevant relationships with ineligible companies to disclose | No |
Michael Oldenburg, MD | Speaker | No relevant relationships with ineligible companies to disclose | Yes |
Ian Joseph Rodriguez, MS | Speaker | No relevant relationships with ineligible companies to disclose | No |
Nathan Schreiber, MD | Speaker | No relevant relationships with ineligible companies to disclose | No |
Alex Shum, MD | Speaker | No relevant relationships with ineligible companies to disclose | No |
Brian Sieck, MD | Committee Member, Speaker | No relevant relationships with ineligible companies to disclose | No |
Courtney Tipton, MD | Speaker | No relevant relationships with ineligible companies to disclose | No |
Oscar Villarreal Espinosa, MS | Speaker | No relevant relationships with ineligible companies to disclose | No |
Aaron Wieland, MD | Committee Member, Content Reviewer | No relevant relationships with ineligible companies to disclose | No |
Tyler Willman, MD | Speaker | No relevant relationships with ineligible companies to disclose | No |
ACCREDITATION STATEMENT | |
 | In support of improving patient care, this activity has been planned and implemented by the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) and the Wisconsin Society of Otolaryngology. The University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. |
CREDIT DESIGNATION STATEMENTS | |
American Medical Association (AMA) | The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 7.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. |
Continuing Education Units (CEUs) | The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for .75 continuing education units (CEUs) or 7.5 hours. |
Available Credit
- 7.50 AMA PRA Category 1 Credit™
- 7.50 University of Wisconsin–Madison Continuing Education Hours
- 7.50 Approved for AMA PRA Category 1 Credit™
Questions
For questions about registration, please email [email protected]. For general questions about the conference, please contact Delight Hensler at [email protected].
Program Changes
Emergency situations occasionally occur and may necessitate topic or speaker changes. The University of Wisconsin School of Medicine and Public Health and the University of Wisconsin–Madison ICEP reserve the right to alter or substitute a topic or speaker without prior notification.
Accessibility
The University of Wisconsin provides equal opportunities in employment and programming, including Title IX requirements. The University of Wisconsin fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please notify us at [email protected]